Adalimumab Treats Hidradenitis Suppurativa But Has Multisystem Adverse Event Profile
The effects of adalimumab on HS-PGA and DLQI scores of patients with HS who had been treated at least 6 months were evaluated.
General Dermatology
PPE-Related Skin Conditions and Patient Exposure Main Issues for Dermatologists During COVID-19
The dermatologic aspects of COVID-19 infection are reviewed and identify the skin complications seen and preventative measures that can be taken.
Black Trailblazers in Dermatology Paved Way for Research Innovation, Contemporaries through Extensive Mentoring, Part II
Valerie Harvey, MD and Lynn McKinley-Grant, MD explain the importance of diversity and specialized training to treat patients with skin of color in the field of dermatology.
Tirbanibulin Superior to Placebo for Actinic Keratosis
Tirbanibulin is superior to vehicle at 2 months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence of lesions at one year.
Klisyri Ointment Now Available for Actinic Keratosis
The approval was based on data from 2 multicenter, randomized, double-blind, phase 3 trials (ClinicalTrials.gov: NCT03285477 [N=351] and NCT03285490 [N=351]) that compared the efficacy and safety of Klisyri ointment to placebo in adults with AK on the face or scalp.
The Prevalence and Severity of Pain in Hidradenitis Suppurativa
The prevalence and characteristics of hidradenitits suppurative-related pain in patients was assessed in a large study.
Prevalence of COVID-19-Related Cutaneous Manifestations is Lower in Skin of Color
The prevalence and patterns of cutaneous manifestations in COVID-19 in patients with skin of color is reported.
Improving Photographs of Skin of Color
A summary of tips for capturing high quality images of patients with skin of color is provided.
Assessing the Relationship Between Hidradenitis Suppurativa, Body Mass Index
Baseline BMI and change in BMI of patients with HS and control patients before and after diagnosis of HS were compared.
Are Cutaneous Manifestations Helpful for Diagnosing COVID-19?
The cutaneous signs thus reported as COVID-19 related, their incidence, clinic-pathologic features, and diagnostic and prognostic values are described.
-
Loading...
-
Loading...
Next post in General Dermatology
